Dr. Hafiz Basit Mahboob, MD

Dr. Mahboob practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Mahboob's NPI, 1477947612, was assigned on March 25, 2015. Dr. Mahboob holds Indiana license 01086590A.

Dr. Mahboob's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Mahboob's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Mahboob is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Dr. Mahboob to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahboob practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mahboob's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mahboob is licensed in Indiana.

CMS data shows 1,828 Medicare services from Dr. Mahboob across 18 procedure codes in 2024, for 621 Medicare patients. Medicare paid $176,758 for them.

CMS counts 621 Medicare patients who saw Dr. Mahboob in 2024. The largest group is 65 to 74, with 267 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahboob's median patient age at 72, with 52% women.

In 2024, Dr. Mahboob wrote 1,697 Medicare Part D claims for 276 patients. 49% of them were for generic drugs. CMS names the drug for 1,527 of them, across 28 drugs with 11 or more claims each, at $367,894 in total drug cost. In 2023, CMS named 756 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mahboob for performance year 2024, reported as part of a group. Dr. Mahboob accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Mahboob, published from 2016 to 2020. 2018 was the busiest year, with 2. Dr. Mahboob has published most often in Case Rep Crit Care. Dr. Mahboob's most frequent co-authors are Hafiz Muhammad Abrar Jeelani, Farah Alsaati, MD and Muhammad Asif Bashir, MD.

CMS Open Payments shows 111 general payments to Dr. Mahboob from 19 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 88% of the total. GlaxoSmithKline, LLC. paid the most, $607.